Keyphrases
Mammary Cancer
100%
Organoselenium
100%
Oncogenesis
100%
Chemoprevention
100%
Selenocyanate
100%
7,12-dimethylbenz(a)anthracene
100%
Mammary Tumor Models
75%
Initiation Mechanism
75%
Cyclooxygenase-2
75%
Benzyl
75%
8-hydroxydeoxyguanosine (8-OHdG)
50%
Aryl
50%
Primary Metabolites
50%
Glutathione Conjugates
50%
Maximum Tolerated Dose
25%
Induced Apoptosis
25%
Organoselenium Compounds
25%
Dual-labeling
25%
Celsius
25%
Sulphur Analogues
25%
Cancer Chemoprevention
25%
Metabolism Study
25%
Mechanism of Action
25%
Synthetic Organoselenium Compounds
25%
Effective Compounds
25%
Breast Cancer Chemoprevention
25%
Delayed Administration
25%
Clinical Trials
25%
Parent Compounds
25%
Oxidative Damage
25%
Apoptosis
25%
PH Range
25%
Systemic Absorption
25%
Selenoamino Acids
25%
Selenite
25%
Lipid Peroxidation
25%
Extrahepatic Tissues
25%
Methylene
25%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
100%
7,12-Dimethylbenz(a)anthracene
100%
Breast Cancer
100%
Benzyl Selenocyanate
75%
Breast Tumor
75%
Glutathione
50%
Selenol
50%
Organoselenium compounds
50%
Malignant Neoplasm
50%
Isoprostane Derivative
25%
Sulfur
25%
Prostaglandin Synthase
25%
Clinical Trial
25%
Selenoamino Acid
25%
Guanosine
25%
Maximum Tolerated Dose
25%
Lead Compound
25%
Chemistry
Metabolite
100%
Selenocyanate
50%
Anthracene
50%
Glutathione Conjugate
25%
Organoselenium compounds
25%
Cyclooxygenase
12%